Shenzhen, China

Si Qiu

This inventor holds 1 USPTO granted patent. Top assignee: Shenzhen Gino Biotechnology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Si Qiu. Retrieved from https://idiyas.com/inventor/si-qiu-270e89i9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Si Qiu - Innovator in Biotechnology

Introduction

Si Qiu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biotechnology, particularly in the development of tumor-specific polypeptide sequences. His innovative work has the potential to advance cancer treatment and improve patient outcomes.

Latest Patents

Si Qiu holds a patent for a "Tumor-Specific Polypeptide Sequence and Use Thereof." This patent represents a crucial step in the ongoing fight against cancer, showcasing his dedication to medical advancements.

Career Highlights

Si Qiu is currently employed at Shenzhen Gino Biotechnology Co., Ltd. His role at the company allows him to work on cutting-edge research and development projects that aim to enhance therapeutic options for cancer patients.

Collaborations

Si Qiu collaborates with talented individuals such as Bo Li and Youping Li. Their combined expertise fosters an environment of innovation and creativity, driving forward the mission of their organization.

Conclusion

Si Qiu's contributions to biotechnology and his innovative patent highlight his commitment to improving healthcare solutions. His work exemplifies the impact that dedicated inventors can have on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…